Type 2 diabetes mellitus (T2DM) is a serious, chronic, and progressive disease
that is rapidly increasing in prevalence. The disease now affects >10% of adults ...
Drugs. 2006;66(1):85-109. Pioglitazone: a review of its use in type 2 diabetes
mellitus. Waugh J(1), Keating GM, Plosker GL, Easthope S, Robinson DM.
Oct 18, 2006 ... Pioglitazone for type 2 diabetes mellitus. Diseases of the heart and blood vessels
account for approximately 70% of all mortality in people with ...
In clinical trials in patients with type 2 diabetes mellitus, pioglitazone as
monotherapy, or in combination with metformin, repaglinide, insulin or a
Aug 17, 2012 ... The U.S. Food and Drug Administration today approved the first generic version
of Actos (pioglitazone hydrochloride) tablets. Along with diet ...
Dec 29, 2008 ... Type 2 diabetes is an epidemic. Its long-term consequences translate into
enormous human suffering and economic costs; however, much of ...
Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim SH. Pioglitazone for
type 2 diabetes mellitus. Cochrane Database of Systematic Reviews 2006, ...
Dec 16, 2015 ... Benefit/Risk Profile Remains Positive for Pioglitazone as an Important Treatment
Option for Type 2 Diabetes. Takeda Comments on Letters to ...
May 31, 2012 ... Objective To determine if the use of pioglitazone is associated with an increased
risk of incident bladder cancer in people with type 2 diabetes.
patients with type 2 diabetes mellitus, pioglitazone as monotherapy, or in
combination with metformin, repaglinide, insulin, or a sulfonylurea, induced both